Original Articles
Abnormalities in rod photoreceptors, amacrine cells, and horizontal cells in human retinas with retinitis pigmentosa

https://doi.org/10.1016/S0002-9394(99)00401-8Get rights and content
Under a Creative Commons license
open archive

Abstract

PURPOSE: To evaluate changes in the rods and amacrine cells and horizontal cells in human retinas with retinitis pigmentosa.

METHODS: Seven retinas from patient donors with retinitis pigmentosa and 14 age- and postmortem-matched normal human retinas were processed for immunocytochemistry and confocal microscopy. The following cell-specific antibodies were used: anti-rhodopsin (rods), anti–γ-aminobutyric acid (amacrine cells), anticalbindin (cones and horizontal cells), anti–glial fibrillary acidic protein (astrocytes and reactive Müller cells), and anti-synaptophysin and anti-SV2 (synaptic vesicles).

RESULTS: In retinal regions with significant photoreceptor loss, the rods, γ-aminobutyric acid–positive amacrine cells, and calbindin-positive horizontal cells had undergone neurite sprouting. The rod, amacrine and horizontal cell neurites were associated with the surfaces of glial fibrillary acidic protein–immunoreactive Müller cells. Most rod neurites that projected into the inner retina contacted the somata of γ-aminobutyric acid–positive amacrine cells.

CONCLUSIONS: Rods, amacrine and horizontal cells undergo neurite sprouting in human retinas with retinitis pigmentosa. These changes in the retinal neurons may contribute to the electroretinographic abnormalities and progressive decline in vision noted by patients with retinitis pigmentosa. These alterations may also complicate strategies for treatment of retinitis pigmentosa.

Cited by (0)

This study was supported by the following grants (to Dr Milam): Foundation Fighting Blindness, Hunt Valley, Maryland; the Paul and Evanina Bell Mackall Foundation Trust, New York, New York; grants EY01311 and EY01730 from the National Institutes of Health, Bethesda, Maryland; the Chatlos Foundation, Longwood, Florida; and awards from Research to Prevent Blindness, Inc, New York, New York.